Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
Prostin VR 500 micrograms/ml Concentrate for solution for infusion.
| Pharmaceutical Form |
|---|
|
Concentrate for solution for infusion (Sterile concentrate). Clear, colourless solution. |
500 micrograms/ml. Each 1 ml ampoule contains 500 micrograms of alprostadil.
Excipient(s) with known effect: Each ml contains 789 mg ethanol.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Alprostadil |
Alprostadil is chemically identical to prostaglandin E1, the actions of which include vasodilatation of blood vessels in the erectile tissues of the corpora cavernosa and increase in cavernosal artery blood flow, causing penile rigidity. |
| List of Excipients |
|---|
|
Ethanol |
1ml Type I clear glass ampoule.
Multipacks containing 5 × 1 ml ampoules.
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
PL 00057/1031
Date of first authorisation: 23 July 1981
Date of latest renewal: 17 April 1997
| Drug | Countries | |
|---|---|---|
| PROSTIN VR | Canada, Estonia, Hong Kong, Croatia, Israel, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
